Works matching IS 00912700 AND DT 2024 AND VI 64 AND IP 12
Results: 14
Physiologically Based Pharmacokinetic Modeling to Assess the Impact of Pathophysiological Changes in Neonates: Strengths, Weaknesses, and Next Steps.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1606, doi. 10.1002/jcph.6148
- By:
- Publication type:
- Article
Population Pharmacokinetics (PopPK) Support for Pediatric Dosing of Biological Products.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1594, doi. 10.1002/jcph.6116
- By:
- Publication type:
- Article
Pharmacokinetics and Safety of Cilofexor and Firsocostat in Healthy Japanese and Non‐Japanese Participants.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1586, doi. 10.1002/jcph.6114
- By:
- Publication type:
- Article
Effect of Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of SHR4640, a Selective Human Urate Transporter 1 Inhibitor.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1576, doi. 10.1002/jcph.6113
- By:
- Publication type:
- Article
Tracing the Evolution: A Comprehensive Bibliometric Analysis of Drug Interaction Clinical Studies.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1505, doi. 10.1002/jcph.6112
- By:
- Publication type:
- Article
Predict the Drug–Drug Interaction of a Novel PI3Kα/δ Inhibitor, TQ‐B3525, and Its Two Metabolites Using Physiologically Based Pharmacokinetic Modeling.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1517, doi. 10.1002/jcph.6111
- By:
- Publication type:
- Article
Redefining Statin Dosage Post‐Gastric Bypass: Insights from a Population Pharmacokinetics–Pharmacodynamics Link Approach.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1473, doi. 10.1002/jcph.6110
- By:
- Publication type:
- Article
Driving Efficiency: Leveraging Model‐Informed Approaches in 505(b)(2) Regulatory Actions.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1484, doi. 10.1002/jcph.6109
- By:
- Publication type:
- Article
Pharmacokinetics of Dexamethasone in Children and Adolescents with Obesity.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1491, doi. 10.1002/jcph.6108
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Modeling of Vancomycin in Critically Ill Neonates: Assessing the Impact of Pathophysiological Changes.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1552, doi. 10.1002/jcph.6107
- By:
- Publication type:
- Article
Multiple‐dose pharmacokinetics of cenerimod and the effect of charcoal on its elimination.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1566, doi. 10.1002/jcph.6106
- By:
- Publication type:
- Article
Influence of Dapagliflozin Dosing on Low‐Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus: A Systematic Literature Review and Meta‐Analysis.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1528, doi. 10.1002/jcph.6105
- By:
- Publication type:
- Article
Effects of Food, Gastric Acid Reduction, and Strong CYP3A Induction on the Pharmacokinetics of Tasurgratinib, a Novel Selective Fibroblast Growth Factor Receptor Inhibitor.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1541, doi. 10.1002/jcph.6104
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1467, doi. 10.1002/jcph.2086
- Publication type:
- Article